IHH Healthcare Berhad Full Year 2024 Earnings: Beats Expectations

Simply Wall St

IHH Healthcare Berhad (KLSE:IHH) Full Year 2024 Results

Key Financial Results

  • Revenue: RM25.1b (up 20% from FY 2023).
  • Net income: RM2.66b (down 10.0% from FY 2023).
  • Profit margin: 11% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: RM0.30 (down from RM0.34 in FY 2023).
KLSE:IHH Earnings and Revenue Growth February 28th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

IHH Healthcare Berhad Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 4.6%. Earnings per share (EPS) also surpassed analyst estimates by 32%.

Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Healthcare industry in Malaysia.

Performance of the Malaysian Healthcare industry.

The company's shares are up 2.6% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of IHH Healthcare Berhad's balance sheet and an in-depth analysis of the company's financial position.

Valuation is complex, but we're here to simplify it.

Discover if IHH Healthcare Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.